BioCentury | Jul 7, 2017
Company News

Acer finds public path via Opexa merger

...The Woodlands, Texas Business: Endocrine/Metabolic Jaime De Leon ACER-001 ACER-002 celiprolol Edsivo imilecleucel-T T-cell vaccine Tcelna Acer Therapeutics Inc. Opexa Therapeutics Inc. Adrenergic receptor beta 1 (ADRB1) Branched chain ketoacid dehydrogenase kinase (BCKDK) (BDK) T...
BioCentury | Jul 3, 2017
Company News

Acer finds public path via Opexa merger

...77%) to $1.15 on Monday. Jaime De Leon ACER-001 ACER-002 imilecleucel-T OPX-212 Tcelna Acer Therapeutics Inc. Opexa Therapeutics Inc. Adrenergic receptor beta 1 (ADRB1) Aquaporin-4 (AQP4) Branched chain ketoacid dehydrogenase kinase (BCKDK) (BDK) T...
BioCentury | Jun 20, 2013
Distillery Therapeutics

Indication: Endocrine/metabolic disease

...information Endocrine/metabolic disease Endocrine/metabolic disease Branched chain ketoacid dehydrogenase kinase (BCKDK; BDK) In vitro and mouse studies identified a BDK...
...amino acids (BCAAs), including the genetic disorder branched-chain ketoaciduria, obesity and diabetes. Crystal structures of BDK...
...allosteric site. In wild-type mice, injection of the compound decreased both plasma BCAA levels and BDK...
Items per page:
1 - 3 of 3